<- Go Home
Natus Medical Incorporated
Natus Medical Incorporated provides medical device solutions focuses on the diagnosis and treatment of patients with central nervous and sensory system disorders worldwide. It offers products and technologies used for the screening, detection, treatment, monitoring, and tracking of common medical ailments in newborn care, hearing impairment, neurological and neurosurgical treatments, epilepsy, sleep disorders, and neuromuscular diseases. The company also provides computerized neurodiagnostic systems for audiology, neurology, polysomnography, and neonatology; and software systems for managing and tracking disorders and diseases for public health laboratories. In addition, it offers electroencephalography, long term monitoring, intensive care unit monitoring, electromyography, sleep analysis or polysomnography, and intra-operative monitoring solutions. Further, the company provides hearing assessment, screening, and instrument fitting solutions; jaundice management products; brain injury products; and eye imaging systems and products used in the advanced science and practice of neonatal and pediatric retinal imaging. Additionally, it offers essential products used in the everyday operation of neonatal intensive care unit (NICU); balance assessment systems to evaluate patients with balance disorders; and NICVIEW, a live streaming video for families with babies in the NICU. The company also provides computer-based audiological, otoneurologic, and vestibular instrumentation for hearing and balance care professionals. It serves university medical centers, public and private hospitals, physician offices, clinics, research laboratories, and others. The company was formerly known as ALGOTEK Instruments, Inc. The company was founded in 1987 and is based in Middleton, Wisconsin with additional locations in Schaumburg, Illinois; Oakville and Kanata, Canada; Taastrup, Denmark; Planegg, Germany; Merignac and Massy, France; Galway, Ireland; Bicester, United Kingdom; Montegrotto Terme, Italy; Madrid, Spain; Ede, the Netherlands; Newington, Australia; Auckland, New Zealand; and Shanghai, China.
Market Cap
$1.1B
Volume
143.5K
Cash and Equivalents
$84.3M
EBITDA
$58.3M
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
$278.7M
Profit Margin
58.27%
52 Week High
$33.93
52 Week Low
$20.90
Dividend
N/A
Price / Book Value
2.62
Price / Earnings
87.82
Price / Tangible Book Value
5.07
Enterprise Value
$1.1B
Enterprise Value / EBITDA
16.00
Operating Income
$30.9M
Return on Equity
3.02%
Return on Assets
3.36
Cash and Short Term Investments
$84.3M
Debt
$10.2M
Equity
$430.9M
Revenue
$478.3M
Unlevered FCF
$53.7M
Sector
Health Care Equipment and Supplies
Category
N/A
Hedge Funds that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).
Upgrade to Yellowbrick PremiumYellowbrick Portfolios that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).
Upgrade to Yellowbrick Premium